StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology operating margin

Operating margin is operating income as a percentage of revenue.

Regenerative Medical Technology's operating margin for the twelve months ending Jun 30, 2026 was 0.5%. For fiscal 2025 it was -17.0%, against 2.0% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-17.0%−19.0
FY2024Dec 31, 20242.0%+31.7
FY2023Dec 31, 2023-29.7%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202614.1%+39.5
Q1 FY2026Mar 31, 20268.7%−1.2
Q4 FY2025Dec 31, 2025-19.5%−44.7
Q3 FY2025Sep 30, 2025-37.8%−39.8
Q2 FY2025Jun 30, 2025-25.4%+1.5
Q1 FY2025Mar 31, 20259.9%+22.8
Q4 FY2024Dec 31, 202425.2%–
Q3 FY2024Sep 30, 20242.0%–
Q2 FY2024Jun 30, 2024-27.0%–
Q1 FY2024Mar 31, 2024-12.9%–

More Regenerative Medical Technology figures

See a number that looks wrong?